To investigate the mechanisms by which TP53 mutations influence GBM, we performed differential expression genes (DEGs) analysis on transcriptomic data from patients with TP53 mutations and those with WT TP53 (Fig. 1E, F). The gene discussed is TP53; the disease is glioblastoma.